US Patent 11325969 FGL2 antibodies and binding fragments thereof and uses thereof
Article
The disclosure is directed to antibodies and binding fragments thereof that specifically bind FGL2. The disclosure is also directed to uses of the antibodies and binding fragments thereof for treating cancer.